IntelliPlex™ Lung Cancer Gene Mutation Panel

The IntelliPlex™ Lung Cancer Gene Mutation Panel is a qualitative molecular assay for the detection of 36 DNA mutations of KRAS, NRAS, PIK3CA, BRAF and EGFR genes as well as 19 gene rearrangements of ALK, ROS1, RET, NTRK1 and MET genes. All known 55 mutations can be identified in two wells by using πCodeTM technology along with the SelectAmp PCR Technology, which enables increased sensitivity, allowing for potential applications such as liquid biopsy tests.


Benefits —

  • Complete set of mutations for lung cancer
  • Two-well multiplex assay for DNA mutations and gene rearrangements
  • Low sample input required
  • Highly specific and sensitive
  • Applied in FFPE




 Product under development